Status:
RECRUITING
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Lead Sponsor:
Loma Linda University
Conditions:
Radiation Exposure
Overactive Bladder
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radi...
Detailed Description
Patients scheduled for lead implantation during sacral neuromodulation in the operating room and consent will be included in this study. Placement of the lead in the operating room with fluoroscopy is...
Eligibility Criteria
Inclusion
- Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.
Exclusion
- neurogenic bladder, BMI \>40, or peripheral neuropathy.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04527445
Start Date
January 1 2026
End Date
December 1 2026
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Health
Loma Linda, California, United States, 92354